STSN.US Stemsation International Inc

Healthcare Pharmaceuticals USA Stocks
0.0115 USD
Close of Nov 18, 2026
0.0024 0.0205
Market cap
USD 7.14M
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is STSN.US undervalued?

Graham number

The Graham number of Stemsation International Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Stemsation International Inc fundamental analysis

No fundamental analysis for Stemsation International Inc yet.

Stemsation International Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Stemsation International Inc

Stemsation International, Inc. researches, develops, manufactures, and sells canned and flavored oxygen products in the United States. It sells its products from business to business and direct to consumers channels. The company was incorporated in 2006 and is headquartered in Plantation, Florida.

Full company profile